Seeing Is Believing
TVTX is currently covered by 10 analysts with an average price target of $42.13. This is a potential upside of $15.34 (57.26%) from yesterday's end of day stock price of $26.79.
Travere Therapeutics's activity chart (see below) currently has 216 price targets and 149 ratings on display. The stock rating distribution of TVTX is 80% BUY and 20% HOLD.
Analysts average stock forecasts to be materialized ratio is 65.24% with an average time for these price targets to be met of 429.63 days.
Highest price target for TVTX is $47, Lowest price target is $30, average price target is $38.3.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 28-Nov-2025.
Currently out of the existing stock ratings of TVTX, 16 are a BUY (80%), 4 are a HOLD (20%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Jul-2025
$47
$20.16 (75.11%)
$47
3 months 25 days ago
(28-Nov-2025)
1/5 (20%)
$11.59 (32.73%)
122
Hold Since 13-Dec-2022
$31
$4.16 (15.50%)
$20
4 months 22 days ago
(31-Oct-2025)
8/9 (88.89%)
$-4.16 (-11.83%)
117
Buy Since 22-May-2023
$40
$13.16 (49.03%)
$24
4 months 22 days ago
(31-Oct-2025)
7/7 (100%)
$4.84 (13.77%)
335
Buy Since 21-Oct-2024
$35
$8.16 (30.40%)
$27
6 months 14 days ago
(11-Sep-2025)
4/4 (100%)
$10 (40.00%)
131
Buy Since 26-May-2021
$31
$4.16 (15.50%)
$31
7 months 18 days ago
(07-Aug-2025)
10/12 (83.33%)
$14.09 (83.32%)
357
What is TVTX (Travere Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on TVTX (Travere Therapeutics) with a proven track record?
Which analyst has the most public recommendations on TVTX (Travere Therapeutics)?
Which analyst is the currently most bullish on TVTX (Travere Therapeutics)?
Which analyst is the currently most reserved on TVTX (Travere Therapeutics)?